UK hydrogen technology company Clean Power Hydrogen (CPH2) has signed an agreement with Kenera Energy Solutions, a unit of UK-headquartered KCA Deutag, to manufacture and sell its electrolysers in Europe and the Middle East.

The non-exclusive licence allows Kenera to manufacture and sell 150 electrolyser units per year in Germany, Scotland, Azerbaijan, Denmark and Norway and a maximum of 2GW of capacity in Saudi Arabia, the UAE, Qatar, Kuwait and Iraq.

2-4GW/yr – CPH2 2030 production target

“We are delighted to enter into this agreement with Kenera, whose parent company, KCA Deutag, is not only an investor in CPH2, but is also one of the leading energy sector manufacturing businesses in the world, adding valuable and immediate manufacturing capacity,” says Jon Duffy, CEO of CPH2.

The company’s intellectual property strategy is to offer proprietary technology to manufacturing partners, resulting in a low-cost business model that will still allow it a good level of market penetration. It has a 2030 production target of 2-4GW/yr, with 1GW made at its own facility and the rest manufactured under licence by other companies.

Strategy success

CPH2 last month signed a 20-year deal for the production of 2GW of its patented membrane-free electrolysers under licence by renewables joint venture GHFG at a new facility in Ireland. Production under the deal is expected to start in 2023.

CPH2’s membrane-free electrolyser (MFE) technology uses cryogenic separation to deliver pure hydrogen and pure oxygen as separate gases. Its design means it does not use platinum group metals, and CPH2 says it is the most cost-effective alternative to proton-exchange-membrane (PEM) electrolysers.

MFE technology can also match the performance of PEM electrolysers in terms of accommodating the fluctuations in power supply that come with the use of intermittent renewables, the firm says.

---

Author: Tom Young